Samsung Biologics Co. Ltd.
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Samsung Biologics expands presence in Greater China Region with CDO partnership for Alzheimer's candidate 2020-03-17 08:04
Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug 2020-03-03 03:00
Samsung Biologics Confirms 'No Impact' of COVID-19 with Business Continuity Plan in Effect 2020-02-27 15:49
Samsung Biologics Reports 64% Jump in FY19 Earnings, Sees Global Expansion in 2020 2020-02-04 13:50
Samsung Biologics Enhances Its Trusted Service as the First and Only ISO27001 Certified CDMO 2019-11-14 20:00
Samsung Biologics and Ichnos Sciences Announce Agreement for Manufacture of ISB 830 2019-11-05 08:22
Samsung BioLogics Implements Large Scale N-1 Perfusion for Commercial Application 2019-08-12 19:00
Samsung BioLogics and UCB Sign Third Drug Manufacturing Deal 2019-07-31 19:00
CytoDyn and Samsung BioLogics Formalize Manufacturing Partnership 2019-05-30 19:00
Samsung BioLogics to Showcase End-to-End CDMO Capabilities at BIO International 2019 2019-05-29 12:27
Samsung BioLogics signs CDO(Contract Development Organization) contract with GI Innovation 2019-05-03 14:36
Samsung BioLogics Wins 2019 CMO Leadership Awards in All Six Core Categories Three Years in a Row 2019-03-21 13:42
Samsung BioLogics named a Fortune Future 50 company 2018-10-19 09:48
1 2 3 4 5